SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-23-000142
Filing Date
2023-07-27
Accepted
2023-07-27 16:48:59
Documents
20
Period of Report
2023-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20230721.htm   iXBRL 8-K 31843
2 EX-99.1 formofletteragreement726.htm EX-99.1 30906
6 formofletteragreement726001.jpg GRAPHIC 207302
7 formofletteragreement726002.jpg GRAPHIC 265865
8 formofletteragreement726003.jpg GRAPHIC 252946
9 formofletteragreement726004.jpg GRAPHIC 58166
10 formofletteragreement726005.jpg GRAPHIC 235026
11 formofletteragreement726006.jpg GRAPHIC 234642
12 formofletteragreement726007.jpg GRAPHIC 78049
  Complete submission text file 0001367644-23-000142.txt   2038716

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20230721.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20230721_lab.xml EX-101.LAB 25156
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20230721_pre.xml EX-101.PRE 13102
14 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20230721_htm.xml XML 2923
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 231119179
SIC: 2834 Pharmaceutical Preparations